Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis-Reference-Cited by-同舟云学术

Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis

Published:2007 Issue:6 Volume:45 Page:1366-1374
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Yamaguchi Kanji,Yang Liu,McCall Shannon,Huang Jiawen,Yu Xing Xian,Pandey Sanjay K.,Bhanot Sanjay,Monia Brett P.,Li Yin-Xiong,Diehl Anna Mae

Publisher

Wiley

Subject

Hepatology

Reference32 articles.

1. Nonalcoholic Fatty Liver Disease

2. Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity

3. Nonalcoholic Fatty Liver Disease

4. Insulin Resistance Syndrome and Nonalcoholic Fatty Liver Disease

5. Cloning of DGAT2, a Second Mammalian Diacylglycerol Acyltransferase, and Related Family Members

Cited by 869 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipidomics and transcriptomics analysis revealed the role of the spleen of Nile tilapia (Oreochromis niloticus) in lipid metabolism;Aquaculture;2024-11

2. Targeting hepatic macrophages for non-alcoholic fatty liver disease therapy;Frontiers in Cell and Developmental Biology;2024-09-05

3. DGAT1 and DGAT2 Inhibitors for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Management: Benefits for Their Single or Combined Application;International Journal of Molecular Sciences;2024-08-21

4. Legacy and alternative per- and polyfluoroalkyl substances (PFAS) alter the lipid profile of HepaRG cells;Toxicology;2024-08

5. Application and research progress of magnetic resonance proton density fat fraction in metabolic dysfunction-associated steatotic liver disease: a comprehensive review;Abdominal Radiology;2024-07-24